DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells.
Conference Paper
Publication Date:
2008
Iris type:
04.01 Contributo in Atti di convegno
List of contributors: